mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0078 |
0.8 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.8 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
0.0079 |
0.8 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.0076 |
0.8 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.8 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.8 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.8 |